Publications by authors named "Linda Colangelo"

Claim this Profile
L
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Linda H Colangelo

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
Patricia A Ganz, Ron D Hays, Karen L Spritzer, André Rogatko, Clifford Y Ko, Linda H Colangelo

Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.
Osama E Rahma, Greg Yothers, Theodore S Hong, Marcia M Russell, Y Nancy You, Linda H Colangelo

JAMA Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer.
Kathryn L Penney, Barbara L Banbury, Stephanie Bien, Tabitha A Harrison, Xinwei Hua, Linda H Colangelo

Clin Gastroenterol Hepatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG Oncology.
Shonan Sho, Greg Yothers, Linda H Colangelo, Patricia A Ganz, Michael J O'Connell

Dis Colon Rectum· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Joanne L Blum, Patrick J Flynn, Greg Yothers, Lina Asmar, Charles E Geyer, Linda H Colangelo

J Clin Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
Michael J O'Connell, Linda H Colangelo, Robert W Beart, Nicholas J Petrelli, Carmen J Allegra

J Clin Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08.
Kay Pogue-Geile, Greg Yothers, Yusuke Taniyama, Noriko Tanaka, Patrick Gavin, Linda Colangelo

J Natl Cancer Inst· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.
Jacek A Kopec, Linda H Colangelo, Stephanie R Land, Thomas B Julian, Ann M Brown

J Support Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.
Patrick G Gavin, Linda H Colangelo, Debora Fumagalli, Noriko Tanaka, Matthew Y Remillard

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.
Greg Yothers, Michael J O'Connell, Carmen J Allegra, J Philip Kuebler, Linda H Colangelo

J Clin Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
Carmen J Allegra, Greg Yothers, Michael J O'Connell, Saima Sharif, Nicholas J Petrelli, Linda H Colangelo

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
Mark S Roh, Linda H Colangelo, Michael J O'Connell, Greg Yothers, Melvin Deutsch

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
Carmen J Allegra, Greg Yothers, Michael J O'Connell, Saima Sharif, Linda H Colangelo

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
J Philip Kuebler, Linda Colangelo, Michael J O'Connell, Roy E Smith, Greg Yothers

Cancer· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of microsatellite instability-high remains controversial.
George P Kim, Linda H Colangelo, Soonmyung Paik, Michael J O'Connell, Ilan R Kirsch

J Clin Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Stephanie R Land, Jacek A Kopec, Reena S Cecchini, Patricia A Ganz, H Samuel Wieand, Linda H Colangelo

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, Roy E Smith, Linda H Colangelo

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
George P Kim, Linda H Colangelo, H Samuel Wieand, Soonmyung Paik, Ilan R Kirsch

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
James J Dignam, Blase N Polite, Greg Yothers, Peter Raich, Linda Colangelo

J Natl Cancer Inst· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Barry C Lembersky, H Samuel Wieand, Nicholas J Petrelli, Michael J O'Connell, Linda H Colangelo

J Clin Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
James N Atkins, Samuel A Jacobs, H Samuel Wieand, Roy E Smith, William J John, Linda H Colangelo

Clin Colorectal Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Roy E Smith, Linda Colangelo, H Samuel Wieand, Mirsada Begovic, Norman Wolmark

J Natl Cancer Inst· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Leonard L Gunderson, Daniel J Sargent, Joel E Tepper, Norman Wolmark, Michael J O'Connell, Linda Colangelo

J Clin Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01.
Edwin R Fisher, Linda Colangelo, Samuel Wieand, Bernard Fisher, Norman Wolmark

Dis Colon Rectum· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis